Sprint Offers $2.1 Billion for the Rest of Clearwire

Sprint Nextel (NYSE: S  ) and its subsidiaries have offered approximately $2.1 billion in cash to purchase the shares of Clearwire (UNKNOWN: CLWR.DL  ) they do not already own.

Sprint already owns a majority interest in Clearwire, equal to approximately 51.7% of its outstanding stock. As per a Dec. 11 Schedule 13D filing with the SEC, Sprint would pay for the outstanding shares from "working capital."

Sprint has agreed to pay shareholders $2.90 per share, valuing Clearwire at approximately $4.2 billion. Of the remaining shares outstanding, Comcast (NASDAQ: CMCSA  ) and Intel (NASDAQ: INTC  ) each hold positions in Clearwire. Comcast's approximately 88.5 million shares represent 12.8% of Clearwire's common stock, while Intel's ownership stake is 12.4%.

A Sprint spokesperson declined to comment on the proposed transaction, stating "We are not commenting beyond it [the SEC filing]."

link


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2152904, ~/Articles/ArticleHandler.aspx, 8/23/2014 3:56:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement